J 2009

The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury.

SVOBODA, Petr

Basic information

Original name

The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury.

Name in Czech

The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury.

Name (in English)

The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury.

Authors

SVOBODA, Petr

Edition

Trials, 2009

Other information

Language

Czech

Type of outcome

Článek v odborném periodiku

Field of Study

30211 Orthopaedics

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Faculty of Medicine

Keywords (in Czech)

bradykini - antagonista - mozek - úraz

Keywords in English

bradykinin - antagonist - brain - injury
Změněno: 28/1/2010 14:40, Pavla Hanková

Abstract

ORIG EN

V originále

The trial evaluated safety and effectiveness of the non-peptide bradykinin B2 antagonist Anatibant in the treatment of patients with traumatic brain injury.

In English

The trial evaluated safety and effectiveness of the non-peptide bradykinin B2 antagonist Anatibant in the treatment of patients with traumatic brain injury.